Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 50 - The Real Truth

Pfizer Halts Enrollment In Paxlovid COVID-19 Trial In Standard-Risk Population

Pfizer Inc (NYSE:PFE) shared additional data from the Phase 2/3 EPIC-SR study of Paxlovid (nirmatrelvir and ritonavir tablets) in patients at standard risk for developing severe COVID-19. In previously reported interim analyses, the novel primary endpoint of self-reported, sustained alleviation of all symptoms for four consecutive days was not met. Non-significant 70% relative…

Benzinga

What's hot in life sciences? Bio International Convention looks at what's next as pandemic recedes

It's no secret that during the COVID-19 pandemic, the global life sciences industry shined. It ramped up development of everything from diagnostic tests to new vaccines — including two based on previously unproven messenger RNA technology —all within months instead of years.

Tribune News Service

EU Urges Pfizer To Further Delay COVID-19 Vaccine Deliveries: Reuters

Amid lower demand, Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) agreed to delay supplies of their Covid-19 shot to the European Union. Doses to be shipped from June to August would be sent in September and Q4. Reuters reports that the bloc is putting heat on Pfizer to restrict supplies further. The move comes two weeks after…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters

Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine may relate to a higher risk of heart inflammation in some age groups than Pfizer Inc (NYSE:PFE) - BioNTech SE's (NASDAQ:BNTX) shot, Reuters reported citing the Centers for Disease Control and Prevention. Citing recent data, CDC said that the findings on myocarditis and pericarditis, types of heart inflammation linked to both the…

Benzinga

FDA advisers consider Moderna's COVID shots for older kids

A government advisory panel is meeting to decide whether to recommend a second brand of COVID-19 vaccine for school-age children and teens

The Independent UK

Australia's ResApp Takeover Bid Undervalued - Read What Pfizer Did

Following an independent expert report suggesting that Australia-based ResApp Health Limited's current share price was undervalued, Pfizer Inc (NYSE: PFE) bolstered its takeover bid.

Benzinga

The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 23 strange trades.

Benzinga

The youngest Americans may finally get their COVID shots

Regulators will evaluate both Pfizer-BioNTech and Moderna shots this week.

Axios

Pfizer COVID shot works, safe for youngest kids, FDA says

U.S. Food and Drug Administration staff said that Pfizer Inc.’s COVID-19 shot was effective for kids ages 4 and under with no new safety concerns, in a report released ahead of a key meeting of FDA advisers later this week.

Tribune News Service

US: Pfizer COVID-19 appears effective for kids under 5

A review by federal health officials says that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination

The Independent UK

Research on a deadly bacteria might be a COVID-19 vaccine gamechanger

The Covid-19 pandemic, being truly global, created the demand for vaccines, such as the now-familiar ones from Pfizer, Moderna and AstraZeneca.

Inverse

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

NASA’s hunt for life on Europa hits a major milestone

In today's edition of Inverse Daily, read about the James Webb Space Telescope, Paxlovid and rebound Covid-19 infections, and an interview on Ms. Marvel.

Inverse

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Marathon US hearings to decide fate of COVID shots for tots

Next week brings a marathon of hearings as the U.S. decides whether to open COVID-19 vaccinations to kids under 5

Tribune News Service

Mayo Clinic Minute: What to expect with COVID-19 vaccinations for youngest kids

The Food and Drug Administration (FDA) could grant emergency use authorization of a COVID-19 vaccination for the youngest kids later this month. Pfizer asked the agency to review data and authorize its COVID-19 vaccine for children ages 6 months to 5 years.

ABC News

Malcolm Roberts says a rule change at the WHO 'would have decimated' Australia's sovereignty. Is he correct?

The One Nation senator has continued to push the baseless claim that Australia could be forced to adopt restrictive health measures by the World Health Organization.

Benzinga

US Schedules Covid-19 Vaccines For Children Below Five Years

The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports. The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious. The vaccinations could begin…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Pfizer And 3 Other Stocks Insiders Are Selling

US stock futures traded mixed this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

Inverse

Paxlovid and rebound Covid-19 infections: What you need to know

Some people who take Pfizer's oral antiviral for Covid-19 report testing negative after treatment only to test positive again days later.

Reuters

White House expects COVID vaccine orders for children under 5 to pick up

Pre-orders of vaccines for children under age five have been slow, but Biden administration senior officials say they are not alarmed and expect the pace to pick up after federal approvals later this month.

The Independent UK

Officials: Millions of COVID-19 shots ordered for youngest

White House officials say orders have been coming in for COVID-19 vaccine doses for small children

The Independent UK

New vaccine may be option for troops with religious concerns

A COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the other coronavirus vaccines for religious reasons

Benzinga

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker

Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide strong

ABC News

Adolescents aged 12 to 15 at risk of severe disease able to get COVID-19 booster after government accepts latest ATAGI advice

Australian teenagers aged 12-15 who are at risk of severe disease will be able to receive a COVID-19 booster shot from as early as next week.

1 … 49 50 51 52

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.